###begin article-title 0
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Restriction of HIV-1 Replication in Monocytes Is Abolished by Vpx of SIVsmmPBj
###end article-title 0
###begin p 1
Conceived and designed the experiments: SS BPK. Performed the experiments: SS JKK SH SP. Analyzed the data: SS BPK JKK SH KC MS. Contributed reagents/materials/analysis tools: NW. Wrote the paper: SS KC MS.
###end p 1
###begin p 2
Current address: University of Zurich, Institute of Zoology, Zurich, Switzerland
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 61 91 <span type="species:ncbi:11676">human immunodeficiency virus 1</span>
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 121 126 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 242 271 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 275 290 <span type="species:ncbi:9531">sooty mangabeys</span>
Human primary monocytes are refractory to infection with the human immunodeficiency virus 1 (HIV-1) or transduction with HIV-1-derived vectors. In contrast, efficient single round transduction of monocytes is mediated by vectors derived from simian immunodeficiency virus of sooty mangabeys (SIVsmmPBj), depending on the presence of the viral accessory protein Vpx.
###end p 4
###begin title 5
Methods and Findings
###end title 5
###begin p 6
###xml 97 102 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 160 165 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 246 251 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 343 348 <span type="species:ncbi:9606">human</span>
###xml 396 401 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 625 630 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 634 639 <span type="species:ncbi:9606">human</span>
###xml 671 676 <span type="species:ncbi:9606">human</span>
###xml 718 723 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Here we analyzed whether Vpx of SIVsmmPBj is sufficient for transduction of primary monocytes by HIV-1-derived vectors. To enable incorporation of PBj Vpx into HIV-1 vector particles, a HA-Vpr/Vpx fusion protein was generated. Supplementation of HIV-1 vector particles with this fusion protein was not sufficient to facilitate transduction of human monocytes. However, monocyte transduction with HIV-1-derived vectors was significantly enhanced after delivery of Vpx proteins by virus-like particles (VLPs) derived from SIVsmmPBj. Moreover, pre-incubation with Vpx-containing VLPs restored replication capacity of infectious HIV-1 in human monocytes. In monocytes of non-human primates, single-round transduction with HIV-1 vectors was enabled.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 77 82 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Vpx enhances transduction of primary human and even non-human monocytes with HIV-1-derived vectors, only if delivered in the background of SIVsmmPBj-derived virus-like particles. Thus, for accurate Vpx function the presence of SIVsmmPBj capsid proteins might be required. Vpx is essential to overcome a block of early infection steps in primary monocytes.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 182 190 182 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 190 193 190 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Neil1">[1]</xref>
###xml 195 198 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Sonza1">[2]</xref>
###xml 385 388 385 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Neil1">[1]</xref>
###xml 390 393 390 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mhlebach1">[3]</xref>
###xml 619 622 619 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Neil1">[1]</xref>
###xml 819 822 819 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Sonza2">[4]</xref>
###xml 824 827 824 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Triques1">[5]</xref>
###xml 937 940 937 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Triques1">[5]</xref>
###xml 942 945 942 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Peng1">[6]</xref>
###xml 1008 1014 1008 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 1134 1137 1134 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Sonza2">[4]</xref>
###xml 1139 1142 1139 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Arfi1">[7]</xref>
###xml 1318 1321 1318 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Neil1">[1]</xref>
###xml 1395 1398 1395 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Chiu1">[8]</xref>
###xml 1399 1403 1399 1403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Pion1">[10]</xref>
###xml 113 118 <span type="species:ncbi:9606">human</span>
###xml 166 171 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 242 247 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 453 458 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 513 539 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 541 544 <span type="species:ncbi:11276">VSV</span>
###xml 717 722 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1497 1502 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Compared to more differentiated cells of the hematopoietic lineage such as macrophages or dendritic cells (DCs), human primary monocytes are relatively refractory to HIV-1 infection in vitro[1], [2]. Likewise, lentiviral vectors derived from HIV-1 are not able to mediate efficient monocyte transduction, whereas transduction of monocyte-derived macrophages was possible at low levels [1], [3]. The reason for this difference is not clearly understood. HIV-1 vectors pseudotyped with the envelope glycoprotein of vesicular stomatitis virus (VSV) retain this different transduction capacity for monocytes or macrophages [1], suggesting that the block in monocytes is independent of viral entry by attachment to CD4 or HIV-1 coreceptors. In some studies the block is described as occurring prior to reverse transcription [4], [5], while others suggest that in monocytes an early post entry block occurs shortly after reverse transcription [5], [6]. At least the viral cDNA synthesis and integration seem to be per se extremely inefficient in monocytes since differentiation-dependent cofactors of reverse transcription might be limited [4], [7]. After differentiation of monocytes into DCs, vectors that had already entered the cells were rescued, whereat activation might have induced accumulation of nuclear viral DNA [1]. Different activity of cellular restriction factors like APOBEC proteins [8]-[10] may contribute to the different susceptibility of monocytes and more differentiated cells to HIV-1.
###end p 10
###begin p 11
###xml 192 195 192 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mhlebach1">[3]</xref>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Wolfrum1">[11]</xref>
###xml 409 412 409 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif</italic>
###xml 414 417 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 419 422 419 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpx</italic>
###xml 427 430 427 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 569 572 569 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mhlebach1">[3]</xref>
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Wolfrum1">[11]</xref>
###xml 869 872 869 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mhlebach1">[3]</xref>
###xml 874 878 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Wolfrum1">[11]</xref>
###xml 879 883 879 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Sleigh1">[15]</xref>
###xml 1104 1108 1104 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Fletcher1">[12]</xref>
###xml 1110 1114 1110 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mahalingam1">[16]</xref>
###xml 1115 1119 1115 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Pancio1">[18]</xref>
###xml 1300 1304 1300 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Wolfrum1">[11]</xref>
###xml 1810 1813 1810 1813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Neil1">[1]</xref>
###xml 1815 1818 1815 1818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mhlebach1">[3]</xref>
###xml 1820 1824 1820 1824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Wolfrum1">[11]</xref>
###xml 1826 1830 1826 1830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Schuitemaker1">[19]</xref>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 115 144 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 176 191 <span type="species:ncbi:9531">sooty mangabeys</span>
###xml 625 630 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 1098 1103 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1284 1289 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1353 1358 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1461 1466 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1576 1581 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1757 1762 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1882 1887 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1926 1931 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Recently, we described efficient transduction of primary human monocytes using lentiviral vectors derived from the simian immunodeficiency virus strain SIVsmmPBj isolated from sooty mangabeys [3]. This capacity of SIVsmmPBj vectors depends on the viral protein Vpx, whereas all other accessory genes are dispensable [11]. A vector mutant designated PBj4xko-EGFP, which lacks expression of the accessory genes vif, vpr, vpx and nef was not capable of monocyte transduction. However, this capacity could be restored by supplementation of the PBj4xko-EGFP vector with Vpx [3], [11]. The Vpx protein is encoded by viruses of the HIV-2/SIVsmm/SIVmac lineage and it has been previously described that replication of these viruses or efficient transduction of macrophages or dendritic cells (DCs) with respective vectors strictly depends on the presence of this viral protein [3], [11]-[15]. A number of studies correlated the loss of nuclear localization of the Vpx protein with the inability of mutant viruses to infect non-dividing cells, thus arguing for its role in nuclear import, similar to Vpr of HIV-1 [12], [16]-[18]. To investigate whether Vpx is the only factor required for monocyte transduction with lentiviral vectors, we previously attempted to package Vpx of SIVsmmPBj into HIV-1 particles [11]. In order to achieve this, the p6 domain of the HIV-1 Gag protein was modified to allow binding and packaging of Vpx. However, the resulting Vpx-containing HIV-1 vector particles did not facilitate a more efficiently transduction of primary monocytes than the unmodified HIV-1 vector. The block occurred after reverse transcription of vector RNA and before translocation of the pre-integration complex (PIC) into the nucleus, similar to that shown for HIV-1 vectors or for PBj-derived vectors lacking Vpx [1], [3], [11], [19]. We concluded that Vpx might not be present in the HIV-1 PIC, when delivered with the modified HIV-1 particles, since Vpx may require specific binding to other virus-specific components like integrase, MA or RNA.
###end p 11
###begin p 12
###xml 88 93 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 191 196 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 263 268 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 535 540 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 544 549 <span type="species:ncbi:9606">human</span>
###xml 615 620 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In the present study, two further strategies were conducted to confer Vpx properties to HIV-1-derived vectors. At first, a HA-Vpr/Vpx fusion protein was generated to link Vpx function to the HIV-1 counterpart Vpr in order to mediate packaging of Vpx via Vpr into HIV-1 vector particles and subsequent targeting to the PIC. Furthermore, we attempted to provide Vpx by preincubation of target cells with virus like particles (VLPs) containing Vpx. We analyzed whether Vpx functions enabled single-round infection and full replication of HIV-1 in human and simian monocytes. The results indicate that abolition of the HIV-1 restriction block in monocytes is enabled by Vpx but also requires SIVsmmPBj Gag or Pol functions.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 32 37 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Packaging of SIVsmmPBj Vpx into HIV-1-derived particles using Vpr-Vpx fusion proteins
###end title 14
###begin p 15
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Wolfrum1">[11]</xref>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Wolfrum1">[11]</xref>
###xml 490 498 490 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Kino1">[20]</xref>
###xml 879 886 879 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g001">Fig. 1A</xref>
###xml 96 101 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 136 141 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 239 242 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 308 313 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 355 360 <span type="species:ncbi:9606">human</span>
###xml 507 512 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 607 612 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 670 675 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 744 749 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Previously, we have shown that the Vpx protein of SIVsmmPBj is not incorporated into unmodified HIV-1 vector particles [11]. A modified HIV-1 vector, which carried the Vpx interaction domain of the PBj Gag protein within the corresponding HIV p6 domain, was able to package Vpx. However, this Vpx-containing HIV-1 vector was not able to transduce primary human monocytes [11]. Monocyte transduction was achieved when the SIVsmmPBj-derived PBj4xko-EGFP was supplemented with the Vpx protein in trans. As the HIV-1 counterpart protein Vpr is packaged during virus budding into the particle and is part of the HIV-1 PIC [20], we aimed to enable co-localization of Vpx with HIV-1 Vpr in the target cell by generating a fusion protein consisting of HIV-1 Vpr and PBj Vpx. Schematic representations of the HA-tagged fusion construct as well as of the Vpr and Vpx proteins are shown in Fig. 1A.
###end p 15
###begin title 16
Schematic representation of expression constructs and packaging of Vpr/Vpx fusion proteins into vector particles was detected by Western-blotting.
###end title 16
###begin p 17
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 195 200 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 233 238 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 447 452 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 671 697 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 709 712 <span type="species:ncbi:11276">VSV</span>
###xml 885 888 <span type="species:ncbi:11276">VSV</span>
###xml 923 928 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1341 1344 <span type="species:ncbi:11276">VSV</span>
###xml 1508 1511 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1546 1552 <span type="species:ncbi:9913">bovine</span>
(A) The viral proteins HIV-1 Vpr, SIVsmmPBj1.9 Vpx and related fusion proteins encoded by the expression vector pcDNA3.1. For generation of the fusion protein, the full length Vpx was ligated to HIV-1 Vpr. HA, hemagglutinin tag. (B) HIV-1- or SIVsmmPBj- derived transfer vectors coding for EGFP. In the PBj4xko-EGFP vector, coding regions of all four accessory genes are knocked-out by insertion of stop-codons marked by an asterisk. (C) PBj- and HIV-1-derived packaging constructs coding for Gag-Pol and the regulatory proteins Tat and Rev. These constructs were also used for production of virus-like particles. For pseudotyping of vectors or virus-like particles, the vesicular stomatitis virus G protein (VSV-G, not shown) was used. (D) Western blots of supernatants or lysates of 293T packaging cells cotransfected with the respective vector constructs required for generation of VSV-G-pseudotyped lentiviral vectors (HIV-1 LV or PBj4xko LV), and one of the expression constructs encoding Vpr, Vpx or the Vpr/Vpx fusion protein as indicated on the top. As controls, supernatants and lysates of cells transfected only with one of the Vpr, Vpx or Vpr/Vpx constructs were analyzed. Cell supernatants were purified by filtering and sucrose cushion centrifugation. For labelling, antibodies directed against HA, Vpx, or the envelope protein VSV-G were used. Psi, packaging signal; LTR, long terminal repeat; SD, splice donor; cPPT, central polypurine tract; RRE, rev responsive element; SA, splice acceptor; CMV, cytomegalovirus promoter; BGHpA, bovine growth hormone polyadenylation signal.
###end p 17
###begin p 18
###xml 112 119 112 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g001">Fig. 1B</xref>
###xml 161 168 157 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g001">Fig. 1C</xref>
###xml 392 399 388 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g001">Fig. 1B</xref>
###xml 589 596 585 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g001">Fig. 1D</xref>
###xml 18 23 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 102 105 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 175 178 <span type="species:ncbi:11276">VSV</span>
###xml 668 673 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
For generation of HIV-1 vector particles, 293T cells were co-transfected with the transfer vector pHR-CMV-EGFP (Fig. 1B), the packaging construct pCMVDeltaR8.9 (Fig. 1C), the VSV-G expression plasmid pMD.G and an expression vector encoding for HA-Vpr, Vpx, or HA-Vpr/Vpx fusion protein. SIVsmmPBj vectors were generated likewise but using the vector PBj4xko-EGFP lacking all accessory genes (Fig. 1B). Vector particles were harvested from supernatant, purified by sucrose gradient centrifugation, and analyzed by Western-blotting for the presence of the respective Vpx or HA-Vpr proteins (Fig. 1D). The HA-Vpr/Vpx fusion protein was detected at similar proportions in HIV-1- and PBj4xko-EGFP-derived vector particles. Presence of HA-Vpr, Vpx or HA-Vpr/Vpx proteins in the supernatant fraction indicated successful packaging into vector particles, as in the absence of the Gag-Pol and the envelope constructs none of those proteins were detected. In lysates of packaging cells, comparable expression levels of the respective proteins were determined independently from the presence or absence of the packaging and envelope expression constructs.
###end p 18
###begin p 19
###xml 249 256 249 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007098.s001">Fig. S1</xref>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Fletcher1">[12]</xref>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mahalingam1">[16]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-DiMarzio1">[21]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Selig1">[22]</xref>
To demonstrate integrity of the generated fusion protein, the subcellular localization was analyzed in HeLa cells. In the absence of other viral proteins, HA-tagged Vpr, Vpx and the Vpr/Vpx fusion protein are localized in the nucleus (supplementary Fig. S1), as previously described for similar constructs [12], [16], [21], [22] indicating that localization of the fusion protein as a prerequisite of Vpx function is retained.
###end p 19
###begin title 20
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 105 110 <span type="species:ncbi:9606">human</span>
HIV-1 vector particles supplemented with the HA-Vpr/Vpx fusion protein are not able to transduce primary human monocytes
###end title 20
###begin p 21
###xml 696 699 696 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mhlebach1">[3]</xref>
###xml 891 894 891 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mhlebach1">[3]</xref>
###xml 1168 1175 1168 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g002">Fig. 2A</xref>
###xml 1581 1588 1581 1588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g002">Fig. 2B</xref>
###xml 53 58 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 96 101 <span type="species:ncbi:9606">human</span>
###xml 421 424 <span type="species:ncbi:11276">VSV</span>
###xml 453 458 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1388 1393 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1483 1488 <span type="species:ncbi:9606">human</span>
###xml 1735 1740 <span type="species:ncbi:9606">human</span>
To investigate the capacity of HA-Vpr/Vpx containing HIV-1-derived vectors to transduce primary human monocytes, these cells were isolated from blood of healthy donors by negative depletion and analyzed by FACS for expression of the surface marker CD14. Routinely, the purity of the monocyte population was about 90% (data not shown). Purified cells were transduced at various days post isolation with an MOI of 10 using VSV-G pseudotyped SIVsmmPBj- or HIV-1-derived vector particles supplemented with the HA-Vpr/Vpx fusion protein, HA-Vpr or wild-type Vpx. At the first time point of transduction at day two after isolation, the cells are quiescent monocytes as confirmed by low DNA/RNA content [3].Three days after cultivation, the cells start to differentiate to macrophages, as indicated by increased DNA/RNA content, decreased expression of CD86 surface marker and change of morphology [3], and are designated as monocyte-derived cells. Independent of the day of transduction, application of PBj4xko-EGFP vector particles containing the HA-Vpr/Vpx fusion protein resulted in an approximately 10-fold higher transduction rate, compared to non-supplemented vector (Fig. 2A). The observed transduction efficiency was comparable to that of PBj4xko-EGFP vectors supplemented with wild-type Vpx, indicating that the generated HA-Vpr/Vpx fusion protein is entirely functional. In contrast, HIV-1 vectors containing the HA-Vpr/Vpx fusion protein were not capable of transducing primary human monocytes or monocyte-derived cells with higher efficiency than non-supplemented particles (Fig. 2B). These results indicate that further PBj-specific factors in addition to the Vpx protein might be required for efficient transduction of primary human monocytes.
###end p 21
###begin title 22
###xml 90 95 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Packaging of Vpx into vector particles enhances transduction by SIVsmmPBj-derived but not HIV-1-derived vectors.
###end title 22
###begin p 23
###xml 114 117 <span type="species:ncbi:11276">VSV</span>
###xml 430 435 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Percentage of EGFP-expressing monocytes or monocyte-derived cells transduced at various days post isolation using VSV-G pseudotyped vector particles (MOI 10) supplemented with Vpx, Vpr, or the Vpr/Vpx fusion protein as indicated. The percentage of EGFP-expressing cells was determined by flow cytometry 6 days post transduction. (A) Transduction efficiency of PBj4xko-EGFP-derived vector particles. (B) Transduction efficiency of HIV-1-derived vector particles. Positive control: PBDeltaE-EGFP-derived vector containing all accessory genes. Means of three different donors are shown.
###end p 23
###begin title 24
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 98 103 <span type="species:ncbi:9606">human</span>
Vpx provided by SIVsmmPBj-derived virus-like particles enables HIV-1 vectors to transduce primary human monocytes
###end title 24
###begin p 25
###xml 340 347 340 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g001">Fig. 1C</xref>
###xml 439 445 439 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g001">Fig 1A</xref>
###xml 597 604 597 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g003">Fig. 3A</xref>
###xml 1245 1252 1245 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g003">Fig. 3B</xref>
###xml 1726 1733 1722 1729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g003">Fig. 3C</xref>
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 264 267 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 354 357 <span type="species:ncbi:11276">VSV</span>
###xml 1050 1055 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1288 1293 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1572 1577 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Since packaging of Vpx into HIV-1 vector particles did not result in enhanced monocyte transduction, we attempted to provide Vpx by preincubation of monocytes with Vpx-containing virus-like particles. The VLPs were generated by transfection of 293T cells with the SIV-PBj-derived packaging construct pPBj-psi10 lacking all accessory genes (Fig. 1C), the VSV-G expression construct pMD.G and an expression construct encoding wild-type Vpx (Fig 1A). VLPs were purified from supernatant of transfected cells by sucrose gradient centrifugation, and the presence of Vpx was proven by Western blotting (Fig. 3A). To quantify VLPs, Reverse transcriptase activity was determined and compared to that of PBj vectors of known infectivity on HT1080 cells, assuming that RT activity is equal for infectious and non-infectious particles generated using the same vector genome. Accordingly, after preincubation of target cells with VLPs, the number of VLPs per cell was given as MOI-equivalents (MOIeq). Successive transduction experiments with monocytes using an HIV-1-derived encoding EGFP vector were carried out as described above, but monocytes or monocyte-derived cells were pre-incubated for two hours prior to transduction with VLPs at an MOIeq of 1 (Fig. 3B). Now, efficient transduction with HIV-1 vectors was observed with efficiencies slightly lower than those reached with the positive control vector PBjDeltaE-EGFP containing a functional Vpx. Pre-incubation with VLPs not supplemented with Vpx did not enhance transduction of monocytes or monocyte-derived cells with the HIV-1-derived vector. Transduction of monocytes with PBj4xko-EGFP vector particles was also achieved by pre-incubation of cells with Vpx-containing VLPs (Fig. 3C).
###end p 25
###begin title 26
###xml 64 69 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Vpx-containing SIVsmmPBj-derived VLPs enhance transduction with HIV-1 vectors.
###end title 26
###begin p 27
###xml 162 165 <span type="species:ncbi:11276">VSV</span>
###xml 484 487 <span type="species:ncbi:11276">VSV</span>
###xml 522 527 <span type="species:ncbi:9606">human</span>
###xml 836 841 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Packaging of Vpx into PBj-derived VLPs was detected by Western-blotting. VLPs were generated by cotransfection of the PBj packaging vector pPBj-psi10 and the VSV-G and Vpx expression plasmids. Forty-eight hours post transfection, vector containing supernatant was collected from the 293T cells, filtered and purified twice by ultracentrifugation through a sucrose cushion. Purified VLPs were analyzed on Western blots using antibodies directed against Vpx or the envelope protein VSV-G. (B, C) Transduction of primary human monocytes or monocyte-derived cells 2 h after pre-incubation with Vpx-containing or non-containing PBj-derived VLPs (VLP(PBj)) at an MOIeq of 1 (determined by RT-Assay with standards of known infectivity) as indicated. Percentage of EGFP-expressing cells transduced at various days after isolation using (B) HIV-1 vectors or (C) PBj4xko-EGFP vectors. The percentage of transduced cells was determined by flow cytometry 6 days post transduction. The means of two different donors are shown. (D) Influence of Vpx on activation and differentiation of monocytes or monocyte-derived cells. At the indicated day after isolation, cells were incubated for 48 h with VLPs supplemented with Vpx (+VLPs +Vpx) or not (+VLPs -Vpx) at an MOIeq of 1, in comparison with untreated cells (-VLPs). The surface expression of the markers indicated was determined by FACS analysis. One representative donor out of three is shown.
###end p 27
###begin p 28
###xml 314 321 314 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g003">Fig. 3D</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-JarrossonWuilleme1">[23]</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Poole1">[24]</xref>
To determine a potential influence of Vpx on differentiation and/or activation of the cells, the surface expression of CD11c, CD14, CD86, DC-SIGN and MHCII was analyzed. Monocytes or monocyte-derived cells were incubated at various days after isolation for 48 h with VLPs carrying Vpx or not and analyzed by FACS (Fig. 3D). The slight overall decrease of CD11c, CD14 and CD86 suggested differentiation of monocytes to macrophages during the observation period [23], [24] which was confirmed by absence of the dendritic marker DC-SIGN. The antigen presenting molecule MHC-II and the co-stimulatory molecule CD86 were slightly increased on cells treated at d5 with Vpx-supplemented VLP, indicating a possible Vpx-dependent activation. However, beside these exceptions only marginal differences were detected between untreated and VLP-treated cells. In particular, d2 cells which are most relevant since they are clearly monocytes showed identical expression patterns after treatment with Vpx-carrying or empty VLPs, indicating that differentiation or activation of monocytes by Vpx plays only a minor role for transduction, if any.
###end p 28
###begin p 29
###xml 335 342 335 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g004">Fig. 4A</xref>
###xml 493 500 493 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g004">Fig. 4B</xref>
###xml 461 466 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 750 755 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 840 845 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To describe the effect in dependence of the amount of viral particles, either the amount of vectors or that of VLPs was varied. At first, increasing amounts of VLPs were used for pre-incubation of monocytes. An enhancing effect was already obtained at an MOIeq of 0.1. This effect increased dose-dependently up to an MOIeq of about 1 (Fig. 4A). Next, monocytes were preincubated with VLPs at an MOIeq of 1 and subsequently transduced using different amounts of HIV-1-derived vector particles (Fig. 4B). Transduction rates increased with increasing vector MOI. The highest transduction rate of about 50% was reached with an MOI of 10. In contrast, no transduction was detected after preincubation of monocytes with VLPs lacking Vpx, even at an MOI of HIV-1 vector particles of 10. Transduction efficiency increased only if higher amounts of HIV-1 vector particles were used. The maximum transduction efficiency of about 50% in the presence of Vpx was achieved with an MOI of 10, and in the absence of Vpx with an MOI of 100.
###end p 29
###begin title 30
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 112 117 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 121 126 <span type="species:ncbi:9606">human</span>
Enhancement of HIV-1 transduction of monocytes by PBj-derived VLPs is dose-dependent and enables replication of HIV-1 on human monocytes.
###end title 30
###begin p 31
###xml 215 220 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 406 411 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 662 667 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 793 798 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Percentage of EGFP-expressing cells 6 days post transduction. (A) Monocytes (day 2 post isolation) were pre-incubated for 2 h with increasing amounts of PBj-derived VLPs (VLP(PBj)) as indicated, and transduced with HIV-1 vectors at an MOI of 10. (B) Monocytes were incubated with PBj-derived VLPs at an MOIeq of 1 (determined by RT-Assay with standards of known infectivity), followed by transduction with HIV-1 vectors at increasing MOI as indicated. The means of two different donors are shown. (C) On day 1 post isolation, monocytes were incubated for 2 h with Vpx-containing or non-containing VLPs at an MOIeq of 1 and subsequently infected with CCR5-tropic HIV-1 strain SF165 at an MOI of 0.5. SIVsmmPBj1.9 infection was performed without previous VLP incubation. Replication kinetics of HIV-1 or SIVsmmPBj after pre-incubation of monocytes with VLPs as indicated. Virus replication was assessed by quantifying RT activity in cell culture supernatants. Means of two different donors from one representative out of three experiments are shown.
###end p 31
###begin p 32
###xml 621 625 621 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Fletcher1">[12]</xref>
###xml 627 631 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Sleigh1">[15]</xref>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Hirsch1">[25]</xref>
###xml 955 962 955 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g004">Fig. 4C</xref>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 89 92 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 144 149 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 364 369 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 693 698 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 858 863 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Since single round transduction with HIV-1-derived vectors is enabled by pre-delivery of SIV Vpx, we analyzed whether Vpx also facilitates full HIV-1 replication in these cells. Monocytes were pre-incubated at day 1 post isolation with PBj-derived VLPs either containing or lacking Vpx at an MOIeq of 1 for two hours and subsequently infected with the CCR5-tropic HIV-1 virus strain SF162 at an low MOI of 0.5. Replication was determined by measuring RT-activity in the supernatant of infected cells for 18 days. SIVsmmPBj1.9 wild-type virus which encodes Vpx and is known to efficiently replicate in primary macrophages [12], [15], [25] was used as a control. The replication capacity of the HIV-1 virus was completely rescued when monocytes were treated with Vpx containing VLPs, and was comparable to that of SIVsmmPBj1.9 on untreated cells. In contrast, HIV-1 did not replicate in untreated cells or after pre-incubation with VLPs not containing Vpx (Fig. 4C).
###end p 32
###begin title 33
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Vpx provided by SIVsmmPBj-derived VLPs enables HIV-1 vectors to transduce primary simian monocytes
###end title 33
###begin p 34
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-LaBonte1">[26]</xref>
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Stremlau1">[29]</xref>
###xml 163 171 163 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 293 297 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mariani1">[30]</xref>
###xml 385 389 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Brennan1">[31]</xref>
###xml 944 951 936 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g005">Fig. 5A</xref>
###xml 22 33 <span type="species:ncbi:9598">chimpanzees</span>
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 81 86 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 123 128 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 142 156 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 365 384 <span type="species:ncbi:9545">Pig-tailed macaques</span>
###xml 522 527 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 558 573 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 575 589 <span type="species:ncbi:9544">Macaca mulatta</span>
###xml 594 613 <span type="species:ncbi:9545">Pig-tailed macaques</span>
###xml 615 632 <span type="species:ncbi:9545">Macaca nemestrina</span>
###xml 768 773 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 836 841 <span type="species:ncbi:9606">human</span>
###xml 1053 1071 <span type="species:ncbi:9545">Pig-tailed macaque</span>
###xml 1121 1135 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 1244 1249 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1353 1358 <span type="species:ncbi:9606">human</span>
###xml 1381 1386 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
With the exception of chimpanzees, non-human primates are naturally resistant to HIV-1 infection [26]-[29]. Restriction of HIV-1 infection in rhesus macaque cells in vitro has been attributed to a post-entry step, perhaps due to cellular restriction factors like TRIM5alpha or APOBEC proteins [30], whereas TRIM5alpha restriction has been described to be absent in Pig-tailed macaques [31]. Here, we investigated whether Vpx-containing VLPs can overcome these restrictions and enable transduction of simian monocytes with HIV-1-derived vectors. Monocytes of rhesus macaques (Macaca mulatta) or Pig-tailed macaques (Macaca nemestrina) were isolated, pre-incubated after two days with PBj-derived VLPs at an MOIeq of 1, and subsequently transduced with PBj4xko-EGFP- or HIV-1-derived vectors at an MOI of 8. Efficient transduction of non-human primate monocytes was achieved using both vector types after pre-incubation with Vpx-containing VLPs (Fig. 5A). The transduction efficiency was comparable to that of the SIVsmmPBj-derived PBj4xko-EGFP vector on Pig-tailed macaque monocytes, although the transduction capacity of rhesus macaque cells was slightly higher. In contrast, pre-incubation with VLPs lacking Vpx did not significantly increase HIV-1 transduction of simian monocytes. These results indicate that Vpx allows single-round infection of non-human primate cells with an HIV-1-derived vector.
###end p 34
###begin p 35
###xml 651 658 651 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 772 779 772 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g005">Fig. 5B</xref>
###xml 943 950 943 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007098-g005">Fig. 5B</xref>
###xml 79 84 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 100 105 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 129 134 <span type="species:ncbi:9606">human</span>
###xml 170 189 <span type="species:ncbi:9545">Pig-tailed macaques</span>
###xml 450 455 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 696 701 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 751 770 <span type="species:ncbi:9545">Pig-tailed macaques</span>
###xml 818 823 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Next we analyzed whether overcoming this first blocks of infection would allow HIV-1 replication of HIV-1 wild-type virus on non-human monocytes. Monocytes isolated from Pig-tailed macaques were stimulated for 8 h with TPA to enhance attachment and growth of cells. On day 1 post isolation, monocytes were pre-incubated with Vpx-supplemented or non-supplemented PBj VLPs at an MOIeq of 1 for two hours, and subsequently infected with the CCR5-tropic HIV-1 virus strain SF162 at an MOI of 0.5. Replicating SIVsmmPBj virus was used as control. Replication was determined by measuring RT activity levels in the supernatant of infected cells for 21 days. Results demonstrated that replication of the HIV-1 virus did not occur in monocyte-derived cells of Pig-tailed macaques (Fig. 5B), although single round infections of HIV-1 vectors was enabled in the presence of Vpx. Full replication was observed in control cells infected with SIVsmmPBj1.9 (Fig. 5B).
###end p 35
###begin title 36
###xml 53 58 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
Vpx enables single-round but not full replication of HIV-1 in non-human primate monocytes.
###end title 36
###begin p 37
###xml 63 82 <span type="species:ncbi:9545">Pig-tailed macaques</span>
###xml 216 221 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 353 358 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 386 405 <span type="species:ncbi:9545">Pig-tailed macaques</span>
###xml 565 570 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Transduction of simian monocytes. Monocytes from Rhesus or Pig-tailed macaques were pre-incubated for 2 h with PBj-derived VLPs either containing or lacking Vpx at an MOIeq of 1, and subsequently transduced with HIV-1 or PBj4xko-EGFP vectors at an MOI of 7 as indicated. Means of three animals of each species are shown. (B) Replication kinetics of HIV-1 or SIVsmmPBj. Monocytes of Pig-tailed macaques were stimulated at day 1 post isolation for 8 h with TPA before incubation with VLPs as indicated at an MOIeq of 1, and subsequent infected an MOI of 0.5 with HIV-1 strain SF165 or SIVsmmPBj1.9. Virus replication was assessed by quantifying RT antigen in cell culture supernatants. Means of three different donors out of two independent experiments are shown.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 231 234 231 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Neil1">[1]</xref>
###xml 236 239 236 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mhlebach1">[3]</xref>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-JarrossonWuilleme1">[23]</xref>
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Gruber1">[32]</xref>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Tan1">[33]</xref>
###xml 461 464 461 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mhlebach1">[3]</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Wolfrum1">[11]</xref>
###xml 1065 1068 1065 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mhlebach1">[3]</xref>
###xml 1070 1074 1070 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Wolfrum1">[11]</xref>
###xml 1293 1296 1293 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Neil1">[1]</xref>
###xml 1298 1301 1298 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mhlebach1">[3]</xref>
###xml 1303 1307 1303 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Wolfrum1">[11]</xref>
###xml 1309 1313 1309 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Schuitemaker1">[19]</xref>
###xml 1883 1887 1883 1887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Fletcher1">[12]</xref>
###xml 1889 1893 1889 1893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mahalingam1">[16]</xref>
###xml 1894 1898 1894 1898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Pancio1">[18]</xref>
###xml 2008 2012 2008 2012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Belshan1">[34]</xref>
###xml 2014 2018 2014 2018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Singhal1">[35]</xref>
###xml 134 139 <span type="species:ncbi:9606">human</span>
###xml 225 230 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 571 576 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 777 782 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 815 820 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 870 875 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1005 1010 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1232 1237 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1366 1371 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1614 1619 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1671 1676 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1715 1720 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1873 1878 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2408 2413 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The data presented here emphasizes the essential role of Vpx during the infection of primary monocytes by lentiviral viruses. Primary human monocytes are relatively refractory to single round infection or full replication of HIV-1 [1], [3], albeit efficient infection of monocytes, DCs or macrophages can be achieved by using high amounts of input virus [23], [32], [33]. We described recently that transduction of monocytes with vectors derived from SIVsmmPBj [3], [11] is clearly enhanced in the presence of the viral protein Vpx, which is not encoded by the genome of HIV-1. To determine whether Vpx is the single factor within the SIVsmmPBj derived virus required for transduction of quiescent cells like monocytes, we decided to assign the functional activities of Vpx to HIV-1. To allow packaging of Vpx into HIV-1 derived virus particles, we generated a chimeric HIV-1 vector harboring the p6 domain of the SIVsmmPBj virus. However, Vpx did not enhance transduction of monocytes with this chimeric HIV-1 vector, although efficient packaging was demonstrated [3], [11]. The block occurred after reverse transcription of vector RNA and before translocation of the PIC into the nucleus, similar to that previously described for HIV-1 wild-type vectors or for SIVsmmPBj vectors lacking Vpx [1], [3], [11], [19]. We considered that Vpx might not be present in the HIV-1 PIC to enable trafficking of the PIC into the nucleus, since Vpx requires interaction with other virus specific components such as integrase, MA or RNA. Therefore, two further strategies were pursued to assign functional activities of Vpx to HIV-1-derived vectors. First, we achieved packaging into HIV-1 vector particles by fusing PBj Vpx to HIV-1 Vpr, generating a HA-Vpr/Vpx fusion protein. Like Vpx, Vpr has been described to be present in the PIC and thus might transfer the Vpx protein into the HIV-1 PIC [12], [16]-[18]. Translocation of the PIC into the nucleus can directly be linked to the nuclear localization of Vpx and Vpr [34], [35], and this capacity was retained for the fusion protein HA-Vpr/Vpx. Furthermore, the Vpx part within the HA-Vpr/Vpx fusion protein was still functional in terms of enabling efficient transduction of monocytes, as proven in the context of the PBj4xko-EGFP vector. However, the fusion protein HA-Vpr/Vpx did not enhance transduction of monocytes or monocyte-derived cells if packaged into an HIV-1 vector. We concluded that beside Vpx, other viral components of the PBj-virus are required for efficient monocyte transduction.
###end p 39
###begin p 40
###xml 133 139 133 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 192 200 192 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Goujon1">[13]</xref>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Goujon2">[14]</xref>
###xml 711 715 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Goujon3">[36]</xref>
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 503 508 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 627 632 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 839 844 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 981 986 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1128 1133 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Secondly, we used virus-like particles to assign Vpx functions to HIV-1-derived vectors, thus allowing monocyte transduction. Goujon et al. showed that SIVmac Vpx can be functionally provided in trans by pre-incubation of dendritic cells (DCs) with non-infectious SIVmac-derived virus-like particles (VLPs), which were simply used as carriers of the Vpx proteins [13], [14]. We investigated the suitability of SIVsmmPBj Vpx-containing VLPs derived from SIVsmmPBj to enhance transduction of monocytes by HIV-1 vectors. Remarkably, upon pre-incubation with Vpx-supplemented SIVsmmPBj-derived VLPs, the transduction efficiency of HIV-1 vectors was enhanced 10-fold, which is in line with a very recent publication [36]. By using increasing amounts of VLPs, we could show that the transduction efficiency was dose-dependent. Transduction with HIV-1 vectors was also mediated when the PBj-derived VLPs were supplemented with the HA-Vpr/Vpx fusion protein, but not by supplementation of HIV-1-derived VLPs with HA-Vpr/Vpx (data not shown). Thus, as already concluded from the transduction experiments using Vpx directly packaged into HIV-1 vector particles, it is evident that the Vpx protein is only capable of mediating monocyte transduction if it is delivered in the background of SIVsmmPBj capsids. Whether SIVsmmPBj capsid components are required for efficient release of Vpx from the particles to the cytoplasm, for a certain activation of Vpx, or for nuclear localization of the PIC, remains still elusive.
###end p 40
###begin p 41
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 43 47 43 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Sharova1">[37]</xref>
###xml 258 263 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Wolfrum1">[11]</xref>
###xml 107 112 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 402 407 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 478 483 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 595 600 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In contrast to our findings, Sharova et al.[37] observed an enhancing effect when Vpx was co-packaged into HIV-1 particles. In this case, no further viral components of SIVsmmPBj were necessary, indicating that the restriction mechanism described by Sharova et al. for macrophages may be different from the restriction block present in monocytes investigated by us. In our hands, packaging of Vpx into HIV-1 particles was only possible after insertion of the p6 domain into the HIV-1 genome [11] or after fusion of Vpx to Vpr, thus preventing direct comparison of the function of Vpx-containing HIV-1 particles.
###end p 41
###begin p 42
###xml 56 61 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 232 237 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 802 807 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Remarkably, PBj Vpx did also enable full replication of HIV-1 wild-type virus on human monocytes. Single pre-incubation of monocytes with PBj-derived Vpx-supplemented VLPs was sufficient to promote full replication of a CCR5-tropic HIV-1 virus comparable to that of SIVsmmPBj1.9 wild-type virus encoding Vpx. There are several possible explanations for this observation. It might be possible that the initial infection step during virus replication is most crucial and that once it has entered the nucleus the virus may efficiently replicate in the infected cell. Another explanation might be that Vpx has a sustained effect in the target cells, allowing several rounds of infection. This hypothesis is supported by our own observations that Vpx containing VLPs, delivered to monocytes 20 h before the HIV-1-derived vector still enabled efficient single round transduction (data not shown).
###end p 42
###begin p 43
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Dong1">[38]</xref>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Liou1">[39]</xref>
###xml 567 571 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Goujon1">[13]</xref>
Possible modes of action of Vpx could be by counteracting the function of cellular antiviral genes, or induction of important cofactors lacking in monocytes and required e.g. for cell cycle progression [38], [39]. However, surface marker expression indicative for induction of differentiation or activation like CD11c, CD14, CD86, DC-SIGN or MHC-II were not or only marginally influenced by Vpx provided by VLPs, especially at day two after isolation when all of the cells are still monocytes. Similar results have been described for dendritic cells treated with Vpx [13]. Therefore, we suggest that counteraction of cellular antiviral genes, rather than induction of differentiation or activation, constitutes the functionality of Vpx.
###end p 43
###begin p 44
###xml 328 331 328 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Peng1">[6]</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Pion1">[10]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Peng2">[40]</xref>
###xml 561 563 557 559 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hu</sub>
###xml 915 919 911 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Iwatani1">[41]</xref>
###xml 1005 1009 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Goujon1">[13]</xref>
###xml 1011 1015 1007 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Goujon2">[14]</xref>
###xml 1017 1021 1013 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Kappes1">[42]</xref>
###xml 1023 1027 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Berger1">[43]</xref>
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 312 317 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 635 640 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 842 847 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1219 1224 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Several proteins mediating retroviral post-entry and post-integration blocks of HIV-1 in monocytes or DCs have been described. As the suppression of protein expression by specific siRNAs against different members of the APOBEC family, namely A3G, A3A and A3F, restored the susceptibility of monocytes and DCs to HIV-1 infection [6], [10], [40], we analyzed the influence of Vpx on APOBEC expression. Recent experiments indicated that pre-incubation of monocytes with Vpx-supplemented PBj-VLPs did not alter either mRNA levels of A3G, A3A, A3F, A3C or Trim5alphahu, protein levels of A3A or A3G, although the transduction efficiency of HIV-1 was significantly enhanced (data not shown). From these experiments we concluded that Vpx may not act as a direct antagonist of APOBEC proteins. APOBEC3G has been described to impair the initiation of HIV-1 reverse transcription and/or processivity of reverse transcription [41]. The accumulation of RT products in DCs was strongly enhanced in the presence of Vpx [13], [14], [42], [43], which indicates that Vpx counteracts the restriction during reverse transcriptions. Since transduction of monocytes was also enhanced when the Vpx containing VLPs were added up to 20 h post HIV-1 transduction (data not shown), it might be likely that the restriction occurs just before translocation of the PIC in the nucleus or even in the nucleus, before integration. However, it remains still elusive in which way Vpx might counteract different APOBEC or Trim5alpha restriction pathways, considering that we have not observed a change in APOBEC gene expression.
###end p 44
###begin p 45
###xml 147 151 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Stremlau1">[29]</xref>
###xml 153 157 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Sakuma1">[44]</xref>
###xml 158 162 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Stremlau2">[46]</xref>
###xml 269 270 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 426 430 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Brennan1">[31]</xref>
###xml 760 764 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Shi1">[47]</xref>
###xml 766 770 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Sokolskaja1">[48]</xref>
###xml 1091 1095 1079 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Goujon2">[14]</xref>
###xml 1114 1118 1102 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Singhal1">[35]</xref>
###xml 1120 1124 1108 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Singhal2">[49]</xref>
###xml 1464 1468 1452 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Sakuma1">[44]</xref>
###xml 1470 1474 1458 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Sakuma3">[50]</xref>
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 219 224 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 232 237 <span type="species:ncbi:9606">human</span>
###xml 282 297 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 301 320 <span type="species:ncbi:9545">Pig-tailed macaques</span>
###xml 325 343 <span type="species:ncbi:9545">Pig-tailed macaque</span>
###xml 351 356 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 405 419 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 527 532 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 618 623 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 832 837 <span type="species:ncbi:9606">human</span>
###xml 895 900 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1037 1042 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1129 1134 <span type="species:ncbi:9606">human</span>
###xml 1150 1155 <span type="species:ncbi:9606">human</span>
###xml 1178 1183 <span type="species:ncbi:9606">human</span>
###xml 1255 1260 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1295 1300 <span type="species:ncbi:9606">human</span>
###xml 1380 1385 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
For non-human primate cells, additional species specific pre- and post- integration blocks of retroviruses, such as Trim5alpha have been described [29], [44]-[46]. To analyze, whether Vpx does circumvent restriction of HIV-1 in non-human primate cells, we isolated CD14+ cells from rhesus macaques or Pig-tailed macaques. In Pig-tailed macaque cells, HIV-1 infection is not restricted by Trim5alpha as in rhesus macaque cells [31]. Remarkably, we could show an enhanced transduction of monocytes from both simian species using HIV-1-derived vectors. Pre-incubation with VLPs not supplemented with Vpx did not increase HIV-1 transduction efficiency. Thus a simple saturation of restriction factors by Gag or Pol proteins such as described for simian Trim5alpha [47], [48] can be excluded. Vpx allowed a single-round infection of non-human primate monocytes but did not enable full replication of HIV-1 wild-type virus in monocytes from the simian species tested. We conclude that the Vpx protein counteracts restriction of early steps in HIV-1 infection, such as entry, reverse transcription [14] or nuclear import [35], [49], in human as well in non-human primate monocytes. In human monocytes, this is sufficient for complete virus replication. However, HIV-1 replication is not enabled in non-human primate monocytes, which may be attributed to other post-integration blocks of HIV-1 replication which are not counteracted by Vpx, such as simian APOBEC proteins [44], [50].
###end p 45
###begin p 46
###xml 217 225 217 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 104 109 <span type="species:ncbi:9606">human</span>
###xml 162 167 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 252 257 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 407 412 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 441 446 <span type="species:ncbi:9606">human</span>
###xml 526 531 <span type="species:ncbi:9606">human</span>
We suggest that the function of Vpx is to antagonize an antiviral restriction factor present in primary human monocytes. Single-round and productive infection by HIV-1 can be attained by providing the PBj Vpx protein in trans using PBj-derived but not HIV-1-derived particles, the molecular basis for this specificity remains unknown. Using Vpx-supplemented PBj-derived VLPs, the early restriction block of HIV-1 is also circumvented in non-human primate monocytes. However, additional post-integrations blocks not present in human monocytes restrict full virus replication.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48
Plasmids
###end title 48
###begin p 49
###xml 169 172 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mhlebach1">[3]</xref>
###xml 174 178 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Wolfrum1">[11]</xref>
###xml 235 239 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Naldini1">[51]</xref>
###xml 289 293 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Strappe1">[52]</xref>
###xml 400 403 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 441 444 433 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Mhlebach1">[3]</xref>
###xml 610 616 602 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BsaB I</italic>
###xml 621 626 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not I</italic>
###xml 666 669 658 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif</italic>
###xml 671 674 663 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpx</italic>
###xml 676 679 668 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 684 687 676 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 752 755 744 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tat</italic>
###xml 760 763 752 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rev</italic>
###xml 895 898 887 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 184 189 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 226 229 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 479 482 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 561 567 <span type="species:ncbi:9913">bovine</span>
###xml 813 816 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The env-deficient SIVsmmPBj1.9 vector constructs pPBjDeltaE-EGFP and pPBj4xko-EGFP, as well as the expression constructs pcHA-Vpx and pcwt-Vpx were described previously [3], [11]. The HIV-1-derived transfer vector plasmid pHR-CMV-EGFP [51] and the respective packaging construct pCMVdR8.9 [52] were kindly provided by U. Blomer. The SIVsmmPBj1.9-derived packaging construct PBj-psi10 is based on the env-deleted molecular clone pPBjDeltaenv [3]. For construction of PBj-psi10, a CMV promoter was used to replace the 5' LTR, and the 3' LTR was replaced with the bovine growth hormone polyadenylation site using BsaB I and Not I restriction sites. The accessory genes vif, vpx, vpr and nef were deleted by applying fusion PCR, while the regulatory genes tat and rev were maintained. Furthermore, 155 bp between the CMV promoter and the major splice donor (SD) site as well as 59 bp between SD and gag were deleted by fusion PCR, preserving exclusively the primer binding site and the SD. Primer sequences are available upon request.
###end p 49
###begin p 50
###xml 96 99 96 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4-3</sub>
###xml 127 216 127 216 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CGC GGATCC GCC ACC ATG TAC CCC TAC GAC GTG CCC GAC TAC GCC GGC GAA CAA GCC CCA GAA GAC</named-content>
###xml 234 297 234 297 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CCT GGG ATC TGA CAT GCC GCC GGA TCT ACT GGC TCC ATT TCT3&#8242;-3&#8242;</named-content>
###xml 359 417 359 417 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; AAT GGA GCC AGT AGA TCC GGC GGC ATG TCA GAT CCC AGG GAG</named-content>
###xml 437 481 437 481 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CCG CTC GAG TTA TGC TAG TCC TGG AGG GGG A</named-content>
###xml 891 897 891 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamH I</italic>
###xml 902 907 902 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho I</italic>
###xml 88 93 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HA-Vpr/Vpx-expression construct was compiled by fusing PCR fragments generated from HIV-1-NL4-3 and SIVsmmPBj1.9 DNA using 5' CGC GGATCC GCC ACC ATG TAC CCC TAC GAC GTG CCC GAC TAC GCC GGC GAA CAA GCC CCA GAA GAC 3' (forward) and 5' CCT GGG ATC TGA CAT GCC GCC GGA TCT ACT GGC TCC ATT TCT3'-3' (reverse) primers to amplify the Vpr encoding region Vpr and 5' AAT GGA GCC AGT AGA TCC GGC GGC ATG TCA GAT CCC AGG GAG A 3' (forward) and 5' CCG CTC GAG TTA TGC TAG TCC TGG AGG GGG AGG AG 3' (reverse) to amplify the Vpx encoding region, respectively. For fusion of the obtained Vpr and Vpx specific PCR products, the Vpr specific forward primer and the Vpx-specific reverse primer were applied. The amplification product spanning the respective HA-Vpr/Vpx encoding gene was inserted into the mammalian expression vector pcDNA3.1(+) (Invitrogen, Carlsbad, CA, USA) using the restriction sites BamH I and Xho I. All expression constructs were confirmed by DNA sequence analysis (MWG Biotech, Ebersberg, Germany).
###end p 50
###begin title 51
Cell lines
###end title 51
###begin p 52
293T (ATCC; SD 3515), HT1080 (ATCC; CCL121) and HeLa (ATCC CCL-2) were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with penicillin (100 U/ml), streptomycin (100 microg/ml), L-glutamine (2 mM) and 10% FCS.
###end p 52
###begin title 53
Generation and titration of vector and virus-like particles
###end title 53
###begin p 54
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007098-Ory1">[53]</xref>
###xml 163 189 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 206 209 <span type="species:ncbi:11276">VSV</span>
###xml 259 264 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 347 350 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 425 430 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 550 555 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1317 1322 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
For generation of SIVsmmPBj-derived vectors, 293T cells were co-transfected with one of the vector-encoding plasmids described above and pMD.G [53] coding for the vesicular stomatitis virus glycoprotein G (VSV-G) by the calcium phosphate transfection method. HIV-1-derived vectors were generated likewise but using the vector encoding plasmid pHR-CMV-EGFP and the packaging construct pCMVDeltaR8.9. For production of PBj- or HIV-1-derived VLPs, the respective packaging construct was co-transfected with pMD.G. For supplementation of SIVsmmPBj1.9 or HIV-1 vectors or VLPs with Vpx, HA-Vpr or HA-Vpr/Vpx, the respective expression plasmid was additionally co-transfected into vector producing cells. After 48 hours, the vector containing supernatants were collected, filtrated (0.45 microm filter, Sartorius, Gottingen, Germany), concentrated by ultracentrifugation (125,000 x g, 2 h, 4degreesC) through a 20% sucrose cushion and subsequently stored at -80degreesC. For titration, vectors were added in serial dilutions to permissive HT1080 cells seeded in 24-well plates. After 4 h, culture medium was exchanged. Four days later, cells were monitored for EGFP expression by FACS analysis. The amount of VLPs was determined by Lenti RT Activity kit (Cavidi AB, Uppsala, Sweden) and normalized in comparison to PBj- or HIV-1-vectors of known infectivity. For incubation experiments, the amount of VLPs per cell was given as MOI-equivalents (MOIeq).
###end p 54
###begin title 55
###xml 49 54 <span type="species:ncbi:9606">human</span>
Isolation, transduction and infection of primary human and simian monocytes
###end title 55
###begin p 56
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 798 799 789 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 123 138 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 142 161 <span type="species:ncbi:9545">Pig-tailed macaques</span>
###xml 298 303 <span type="species:ncbi:9606">human</span>
###xml 1163 1168 <span type="species:ncbi:9606">human</span>
###xml 1567 1572 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1810 1815 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1924 1929 <span type="species:ncbi:9606">human</span>
###xml 2032 2037 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Primary human CD14+ monocytes were isolated from purified PBMC from healthy donors by negative depletion, and monocytes of rhesus macaques or Pig-tailed macaques by positive selection employing magnetic activated cell sorting (MACS) using the Monocyte Isolation Kit II or the isolation Kit for non-human primate cells, respectively (Miltenyi Biotec, Bergisch Gladbach, Germany). Housing of monkeys and blood donation was maintained in accordance with the German animal license regulations (Tierschutzgesetz). Purity of isolated monocytes was assessed by flow cytometry (FACScantrade mark, Becton Dickinson) analysing expression of the monocyte marker CD14 using a specific phycoerythrin-conjugated monoclonal antibody (BD Bioscience, Heidelberg, Germany). Monocytes were seeded at a density of 4x105 cells/well into 48-well tissue culture plates (BD Falcon, Bedford, MA, USA) and maintained in VLE-RPMI1640 (Biochrom AG, Berlin, Germany) supplemented with penicillin (100 U/ml), streptomycin (100 microg/ml), L-glutamine (2 mM), non essential amino acids (Gibco), 10 ml/L OPI (oxaloacetic acid,. pyruvate and insulin; SIGMA-Aldrich, Taufkirchen, Germany) and 10% human-AB serum (Biochrom AG, Berlin, Germany). For cultivation of simian cells, culture medium was supplied with 10% autologous serum. In some experiments, at the desired day after isolation, monocytes or monocyte-derived cells were pre-exposed for two hours to VLPs where the amount of VLPs per cell was given as MOI-equivalents (MOIeq). For transduction, cells were exposed for 4 h to SIVsmmPBj1.9- or HIV-1-derived vectors. EGFP expression of vector-transduced cells was measured by FACS analysis 6 days post transduction. For analysis of virus replication, monocytes were infected in triplicate on day 1 post isolation with an MOI of 0.5 with HIV-1 or SIVsmmPBj strains and cultured up to day 21. Before infection with the respective wild type viruses, non-human primate cells were pre-stimulated for 8 h with 20 ng/ml TPA. To determine the amount of SIVsmmPBj and HIV-1, supernatants (200 microl) were collected and the amount of reverse transcriptase activity was determined by Lenti RT Activity kit (Cavidi AB, Uppsala, Sweden).
###end p 56
###begin p 57
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
For determination of cell surface marker expression, primary monocytes were isolated as described above and seeded at a density of 3x106 cells/well into 6-well tissue culture plates (BD Falcon, Bedford, MA, USA). On day 2, 5 and 9 post isolation, cells were cultivated for 48 h in the presence of PBj-derived VLPs at an MOIeq of 1. The cells were stained with alphaCD11c-FITC (Acris GmbH, Herford, Germany) alphaCD14-PE (DAKO, Hamburg, Germany), alphaCD86-PE (BD-Pharmingen, Heidelberg, Germany), alphaCD209-FITC (Milteny Biotec, Bergisch Gladbach, Germany) or alphaMHC-II-FITC (DAKO) and analyzed by flow cytometry (LSR II; Becton Dickinson, Heidelberg, Germany). During data analysis with FCS-Express (DeNovo Software, Los Angeles, USA) the isotype controls were matched.
###end p 57
###begin title 58
Detection of virion proteins by Western blotting
###end title 58
###begin p 59
Vector or VLP-containing supernatants were clarified by filtration (0.45 microm filter) and concentrated by ultracentrifugation through a 20% sucrose cushion (125,000 x g, 2 h, 4degreesC). Subsequently, viral particles were resuspended in 1 ml of PBS (4degreesC) and ultracentrifuged through 12 ml of a 20% sucrose cushion (140,000 x g, 1 h, 4degreesC).
###end p 59
###begin p 60
For Western blot analysis, vector particles were resuspended in ice-cold lysis buffer (50 mM HEPES [pH 7.4], 125 mM NaCl, 0.1 mM phenylmethylsulphonyl fluoride, 0.2% NP40), and transfected 293T cells were lysed in ice-cold RIPA buffer (Tris 50 mM, NaCl 150 mM, SDS 0.1%, Na-Deoxycholate 0.5%, 0.1 mM phenylmethylsulphonyl fluoride, NP40 1%), both supplemented with protease inhibitor cocktail (Roche, Mannheim, Germany). Cell lysates were additionally sonicated and protein concentrations were determined by the Bradford method.
###end p 60
###begin p 61
###xml 458 463 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 656 659 <span type="species:ncbi:11276">VSV</span>
Samples were denatured (95degreesC, 5 min) and separated on NuPAGE Novex 4-12% SDS-polyacrylamide gels (Invitrogen, Carlsbad, CA, USA). Following electrophoresis, proteins were transferred to Hybond ECL nitrocellulose membrane (GE Healthcare, Munchen, Germany) by electroblotting, incubated in blocking buffer (5% nonfat dry milk in PBS, 0.1% Tween 20) at room temperature for 1 h and then over night at 4degreesC with the appropriate primary antibody. Anti-HIV-2-Vpx monoclonal antibody (NIH AIDS Research and Reference Reagent Program, Rockville, USA) was used 1:50, anti-HA monoclonal antibody (Covance, Princeton, NJ, USA) was diluted 1:5,000 and anti VSV-G (SIGMA-Aldrich, Taufkirchen, Germany) was diluted 1:10,000. Protein-bound antibodies were detected with HRP-conjugated specific secondary antibodies (diluted 1:7,500 respectively), followed by enhanced chemiluminescence analysis (GE Healthcare, Munchen, Germany).
###end p 61
###begin title 62
Supporting Information
###end title 62
###begin p 63
###xml 434 439 <span type="species:ncbi:10090">mouse</span>
HA-tagged Vpr, Vpx and the Vpr/Vpx fusion protein are localized in the nucleus. HeLa cells transfected using FuGENE reagent with the expression constructs indicated on the left. Two days after transfection, cells were fixed in 4% paraformaldehyde, permeabilized in 0.1% Triton-X-100, and blocked with Image-iT. The HA-tagged Vpx, Vpr or Vpr/Vpx fusion protein were stained with an anti-HA antibody. Monoclonal secondary antibody anti-mouse Alexa Fluor 488, was used together with a Rhodamine Phalloidine solution. Subsequently, 4,6-diamidino-2-phenylindole staining was performed. Finally, cells were embedded in Mowiol and analyzed by confocal laser scanning microscopy. (alpha-HA) Indirect immunofluorescence using anti-HA antibodies and Alexa Fluor 488 conjugated secondary antibody. (DAPI) Staining of nuclei by 4, 6-diamidino-2-phenylindole. (Rhodamin) Staining of cytoplasmatic microfilaments by rhodamin-phalloidine.
###end p 63
###begin p 64
(3.09 MB TIF)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin p 66
###xml 206 209 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
We thank T. Kearns for excellent technical assistance, and M. Renner, E. Flory, C. Munk and C. Hohenadel for constructive discussions. We are grateful to U. Blomer for providing the plasmids pCMVDR8.9, pHR-CMV-GFP. The plasmid pPBj1.9 was a generous gift from P. Fultz.
###end p 66
###begin title 67
References
###end title 67
###begin article-title 68
###xml 25 53 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 83 88 <span type="species:ncbi:9606">human</span>
Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes.
###end article-title 68
###begin article-title 69
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy.
###end article-title 69
###begin article-title 70
###xml 31 36 <span type="species:ncbi:9606">human</span>
Stable transduction of primary human monocytes by simian lentiviral vector PBj.
###end article-title 70
###begin article-title 71
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes.
###end article-title 71
###begin article-title 72
###xml 36 71 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes.
###end article-title 72
###begin article-title 73
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression.
###end article-title 73
###begin article-title 74
###xml 79 114 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1.
###end article-title 74
###begin article-title 75
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
###end article-title 75
###begin article-title 76
###xml 85 90 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo.
###end article-title 76
###begin article-title 77
###xml 81 86 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.
###end article-title 77
###begin article-title 78
Impact of viral accessory proteins of SIVsmmPBj on early steps of infection of quiescent cells.
###end article-title 78
###begin article-title 79
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 109 114 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 115 118 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM).
###end article-title 79
###begin article-title 80
###xml 45 48 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 128 131 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 132 135 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIV(MAC).
###end article-title 80
###begin article-title 81
###xml 6 11 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 110 115 <span type="species:ncbi:9606">human</span>
SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells.
###end article-title 81
###begin article-title 82
Differential association of uracil DNA glycosylase with SIVSM Vpr and Vpx proteins.
###end article-title 82
###begin article-title 83
###xml 27 56 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain.
###end article-title 83
###begin article-title 84
###xml 12 17 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Analysis of HIV-2 Vpx by modeling and insertional mutagenesis.
###end article-title 84
###begin article-title 85
###xml 36 71 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
The C-terminal proline-rich tail of human immunodeficiency virus type 2 Vpx is necessary for nuclear localization of the viral preintegration complex in nondividing cells.
###end article-title 85
###begin article-title 86
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages.
###end article-title 86
###begin article-title 87
###xml 50 85 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1.
###end article-title 87
###begin article-title 88
###xml 87 122 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.
###end article-title 88
###begin article-title 89
Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses.
###end article-title 89
###begin article-title 90
###xml 28 33 <span type="species:ncbi:9606">human</span>
Transduction of nondividing human macrophages with gammaretrovirus-derived vectors.
###end article-title 90
###begin article-title 91
Organic Dust Exposure Alters Monocyte-Derived Dendritic Cell Differentiation and Maturation. Am J Physiol Lung Cell Mol Physiol
###end article-title 91
###begin article-title 92
###xml 54 57 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification.
###end article-title 92
###begin article-title 93
###xml 12 17 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Blockade of HIV-1 infection of New World monkey cells occurs primarily at the stage of virus entry.
###end article-title 93
###begin article-title 94
In defense of the cell: TRIM5alpha interception of mammalian retroviruses.
###end article-title 94
###begin article-title 95
Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.
###end article-title 95
###begin article-title 96
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
###end article-title 96
###begin article-title 97
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.
###end article-title 97
###begin article-title 98
###xml 34 51 <span type="species:ncbi:9545">Macaca nemestrina</span>
Novel TRIM5 isoforms expressed by Macaca nemestrina.
###end article-title 98
###begin article-title 99
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 115 118 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro.
###end article-title 99
###begin article-title 100
###xml 14 19 <span type="species:ncbi:9606">human</span>
Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy.
###end article-title 100
###begin article-title 101
###xml 29 64 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
Conserved amino acids of the human immunodeficiency virus type 2 Vpx nuclear localization signal are critical for nuclear targeting of the viral preintegration complex in non-dividing cells.
###end article-title 101
###begin article-title 102
###xml 0 29 <span type="species:ncbi:11723">Simian immunodeficiency virus</span>
Simian immunodeficiency virus Vpx is imported into the nucleus via importin alpha-dependent and -independent pathways.
###end article-title 102
###begin article-title 103
###xml 20 49 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 56 91 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
###xml 108 113 <span type="species:ncbi:9606">human</span>
Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells.
###end article-title 103
###begin article-title 104
Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction.
###end article-title 104
###begin article-title 105
###xml 31 66 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes.
###end article-title 105
###begin article-title 106
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 83 118 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.
###end article-title 106
###begin article-title 107
###xml 94 99 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.
###end article-title 107
###begin article-title 108
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G.
###end article-title 108
###begin article-title 109
###xml 0 35 <span type="species:ncbi:11709">Human immunodeficiency virus type 2</span>
Human immunodeficiency virus type 2 vpx protein augments viral infectivity.
###end article-title 109
###begin article-title 110
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
SIVMAC Vpx improves the transduction of dendritic cells with nonintegrative HIV-1-derived vectors.
###end article-title 110
###begin article-title 111
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 80 93 <span type="species:ncbi:9544">rhesus monkey</span>
Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells.
###end article-title 111
###begin article-title 112
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Inhibition of HIV-1 replication by simian restriction factors, TRIM5alpha and APOBEC3G.
###end article-title 112
###begin article-title 113
###xml 93 121 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
###end article-title 113
###begin article-title 114
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Saturation of TRIM5 alpha-mediated restriction of HIV-1 infection depends on the stability of the incoming viral capsid.
###end article-title 114
###begin article-title 115
###xml 52 87 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 103 108 <span type="species:ncbi:9606">human</span>
Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
###end article-title 115
###begin article-title 116
Nuclear Export of Simian Immunodeficiency Virus Vpx Protein.
###end article-title 116
###begin article-title 117
###xml 0 13 <span type="species:ncbi:9544">Rhesus monkey</span>
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins.
###end article-title 117
###begin article-title 118
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.
###end article-title 118
###begin article-title 119
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 100 105 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 110 113 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 135 142 <span type="species:ncbi:57667">SIV/HIV</span>
Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usage.
###end article-title 119
###begin article-title 120
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 83 109 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
###end article-title 120
###begin p 121
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 121
###begin p 122
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was funded by the DFG "Deutsche Forschungsgemeinschaft" (SPP1230 and graduate study program "GK1172 Biologicals" of the Johann Wolfgang Goethe-University Frankfurt a. M. to B.-P. K.) (), and the CliniGene Network of Excellence funded by the European Comission FP6 Research Programme under contract LSHB-CT-2006-018933 (). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 122

